ARTICLE | Company News
Sangamo, Edwards deal
October 22, 2001 7:00 AM UTC
SGMO received a $1.4 million milestone from EW under a 2000 deal to develop treatments for coronary artery disease and peripheral vascular disease. The milestone was triggered by SGMO's delivery of a ...